EMA (EU)
EVENT
Committee for Orphan Medicinal Products (COMP): 11-13 May 2026
Published: 5/11/2026Detected: 4/25/2026
Summary preview
11 May 2026 Committee for Orphan Medicinal Products (COMP): 11-13 May 2026 European Medicines Agency, Amsterdam, the Netherlands Start date: 11 May 2026 End date: 13 May 2026 Event Human Rare diseases.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free account#Orphan Medicinal Products
#Rare Diseases
#Regulatory Events
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system10/12/2026
- First European Medicines Agency (EMA) - International Society for Cell and Gene Therapy (ISCT) bilateral meeting10/12/2026
- Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - October 202610/8/2026
- PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – October 202610/8/2026
- SPOR and XEVMPD status update webinar - Q4 202610/7/2026